Medicine and Dentistry
Meta-Analysis
96%
Systematic Review
95%
Atrial Fibrillation
81%
Congestive Heart Failure
64%
Brugada Syndrome
51%
Risk Stratification
49%
Cohort Analysis
35%
Maturity Onset Diabetes of the Young
33%
Diabetes Mellitus
32%
Sudden Cardiac Death
30%
Cardiovascular System
29%
Cardiovascular Disease
27%
Hazard Ratio
26%
Diseases
25%
Apoplexy
24%
All Cause Mortality
23%
Malignant Neoplasm
23%
Electrocardiogram
23%
Heart Ventricle Arrhythmia
23%
Odds Ratio
22%
Repolarization
21%
COVID-19
20%
Ventricular Tachycardia
19%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Observational Study
18%
Heart Left Ventricle Ejection Fraction
16%
New-Onset Atrial Fibrillation
16%
Faintness
16%
Cardiac Dysrhythmia
16%
Patient with Type 2 Diabetes
15%
Proportional Hazards Model
15%
Ventricular Fibrillation
14%
P Wave
14%
Ablation
14%
T-Peak to T-End
14%
Hemoglobin A1c
12%
Glycon
12%
Brain Ischemia
12%
Ejection Fraction
12%
Dipeptidyl Peptidase-4 Inhibitor
12%
Myocardial Infarction
12%
Comorbidity
12%
Recurrent Disease
11%
Biological Marker
11%
Diabetes
11%
Adverse Outcome
11%
Neutrophil
10%
Heart Atrium Remodeling
10%
Lymphocyte
10%
Prostate Cancer
10%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Congestive Heart Failure
67%
Cohort Study
52%
Diabetes Mellitus
49%
All Cause Mortality
43%
Disease
38%
Heart Arrhythmia
38%
Non Insulin Dependent Diabetes Mellitus
34%
Randomized Controlled Trial
29%
Cardiovascular Disease
29%
Malignant Neoplasm
28%
Sudden Cardiac Death
28%
Heart Ventricle Arrhythmia
27%
Sodium Glucose Cotransporter 2 Inhibitor
27%
Cerebrovascular Accident
24%
Heart Atrium Remodeling
22%
Coronavirinae
20%
Observational Study
18%
Heart Infarction
18%
Arrhythmogenesis
17%
Recurrent Disease
16%
Dipeptidyl Peptidase IV Inhibitor
16%
Heart Ventricle Tachycardia
15%
Immune Checkpoint Inhibitor
15%
Leporidae
15%
Prostate Cancer
14%
Atherosclerosis
14%
New-Onset Atrial Fibrillation
14%
Biological Marker
14%
Metformin
14%
Brugada Syndrome
13%
Hemoglobin A1c
13%
Heptanol
12%
Comorbidity
12%
Androgen
11%
Heart Failure with Preserved Ejection Fraction
11%
Brain Ischemia
11%
Long QT Syndrome
10%
Fibrosis
10%
Combination Therapy
10%
Antiarrhythmic Agent
10%
Heart Ventricle Remodeling
10%
Cardiovascular Risk
10%
Heart Injury
10%
Cardiovascular Mortality
10%
Myocardial Disease
9%
Myocarditis
9%
Ion Channel
9%
Randomized Clinical Trial
9%
Inflammation
9%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
74%
Brugada Syndrome
36%
Cohort Study
27%
Cardiac Dysrhythmia
26%
All Cause Mortality
24%
Repolarization
20%
Ventricular Tachycardia
16%
Oxidative Stress
15%
Heptanol
15%
Electrocardiogram
14%
Action Potential
13%
Observational Study
13%
Medline
12%
Sudden Cardiac Death
11%
Heart Ejection Fraction
10%
Endoplasmic Reticulum Stress
10%
Ventricular Fibrillation
10%
Ion Channel
9%
Cardiac Muscle Cell
9%
Cardiovascular Mortality
9%
Mitochondrial Disorder
9%
Signal Transduction
8%
P Wave
8%
Cochrane Library
8%
Leporidae
8%
Long QT Syndrome
7%
APD90
7%
C-Reactive Protein
7%
Dispersion
7%
Cardiac Resynchronization Therapy
7%
Blood Pressure Variability
7%
Immune Checkpoints
7%
Long Non-Coding RNA
7%
Action Potential Duration
6%
Hypokalemia
6%
Sodium Channel
6%
Randomized Controlled Trial
6%
Mendelian Randomization
5%
Effective Refractory Period
5%
ST Elevation
5%
Prospective Cohort Study
5%
Systolic Blood Pressure
5%
N-Terminus
5%
Body Mass
5%
Embase
5%
